MetLife Investment Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
|
|||||
|
2025
Q1 | $1.14M | Sell |
|
|||||
|
2024
Q4 | $1.95M | Buy |
|
|||||
|
2024
Q3 | $963K | Buy |
|
|||||
|
2024
Q2 | $461K | Buy |
|
|||||
|
2024
Q1 | $99.7K | Buy |
|
|||||
|
2023
Q4 | $95K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $267K | Buy |
|
|||||
|
2023
Q1 | $376K | Buy |
|
|||||
|
2022
Q4 | $458K | Sell |
|
|||||
|
2022
Q3 | $487K | Buy |
|
|||||
|
2022
Q2 | $445K | Sell |
|
|||||
|
2022
Q1 | $549K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.46M | Sell |
|
|||||
|
2019
Q4 | $3.18M | Hold |
|
|||||
|
2019
Q3 | $2.82M | Buy |
|
|||||
|
2019
Q2 | $2.1M | Hold |
|
|||||
|
2019
Q1 | $1.6M | Buy |
|